Adding Drug to Standard Care May Prolong Lymphoma Survival

WEDNESDAY, Sept. 27, 2017 — Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds.
The disease, known as mantle-cell lymphoma, is generally…
Source: Topamax